Aberrant CD8 antigen expression in a patient with B chronic lymphocytic leukaemia showing unusual disease progression

Br J Haematol. 1993 Sep;85(1):205-6. doi: 10.1111/j.1365-2141.1993.tb08673.x.

Abstract

Co-expression of T cell antigens in B-CLL has been well recognized. The commonest T cell antigen known to be expressed in B-CLL is CD5, and recent reports suggest that CD5 expression is associated with good prognosis. Expression of CD8 antigen, however, is much less common with uncertain prognostic significance. We report a case of B-CLL with aberrant CD8 expression, who had unusual disease progression with a fatal outcome.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antigens, Neoplasm / blood*
  • CD8 Antigens / blood*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Male
  • Prognosis

Substances

  • Antigens, Neoplasm
  • CD8 Antigens